How we treat advanced biliary tract cancers in the second-line setting.
Saved in:
| Title: | How we treat advanced biliary tract cancers in the second-line setting. |
|---|---|
| Authors: | Ellis H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wolpin BM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Cleary JM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
| Source: | Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2023 Jan; Vol. 21 (1), pp. 35-42. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1543-0790 |
|---|
